S. Khaksar, M. Gholami
6-Chloro-4-phenyl-2-(p-tolyl)-quinazoline (4i) mp: 213–215 °C; IR (KBr,
1
cm-1): 780, 1,340, 1,568, 1,610; H NMR (400 MHz, CDCl3): d = 2.45 (s, 1H),
7.32 (d, J = 8.0 Hz, 2H), 7.61–7.63 (m, 3H), 7.78–7.87 (m, 3H), 8.07–8.09 (m,
2H), 8.56 (d, J = 9.0 Hz, 2H); 13C NMR (100 MHz, CDCl3): d = 21.4, 121.8,
125.6, 128.1, 128.5, 129.8, 130.1, 130.3, 130.8, 132.3, 134.3, 135.8, 136.9, 141.1,
150.5, 160.4, 167.3.
6-Chloro-2-(4-nitrophenyl)-4-phenylquinazoline (4j) mp: 221–223 °C; IR (KBr,
cm-1): 780, 1,350, 1,560, 1,610; 1H NMR (400 MHz, CDCl3): d = 7.65 (t,
J = 2.8 Hz, 3H), 7.83–7.88 (m, 3H), 8.12 (t, J = 4 Hz, 3H), 8.36 (d, J = 9.0 Hz,
2H), 8.85 (d, J = 8.5 Hz, 2H); 13C NMR (100 MHz, CDCl3): d = 122.5, 123.8,
126.1, 128.9, 129.4, 130.5, 130.6, 131.1,133.9, 135.1, 136.8, 143.6, 149.2, 150.3,
158.1, 168.0.
6-Nitro-2-(2-nitro-phenyl)-4-phenyl-quinazoline (4m) mp: 233–235 °C; IR (KBr,
cm-1): 1,537, 1,345, 1,095, 695; 1H NMR (400 MHz, CDCl3): d = 7.50 (d,
J = 8.7 Hz, 2H), 7.65 (t, J = 2.2 Hz, 3H), 7.86–8.22 (m, 3H), 8.60–8.68 (m, 3H),
9.05 (s, J = 2.5 Hz, 1H); 13C NMR (100 MHz, CDCl3): d = 121.5, 124.3, 128.1,
129.1, 129.4, 130.3, 130.8, 131.2, 131.4, 135.6, 136.3, 138.2, 145.8, 154.5, 162.1.
6-Nitro-2-(4-methylphenyl)-4-phenylquinazoline (4n) mp: 218–220 °C; IR (KBr,
1
cm-1): 775, 1,540, 1,600, 1,655; H NMR (400 MHz, CDCl3): d = 2.45 (s, 3H),
7.35 (d, J = 7.8 Hz, 2H), 7.65–7.88 (m, 5H), 8.24 (d, J = 9.0 Hz, 1H), 8.62 (d,
J = 7.8 Hz, 3H), 9.05 (d, J = 2.2 Hz, 1H); 13C NMR (100 MHz, CDCl3):
d = 21.5, 120.2, 124.1, 126.8, 129.1, 129.3, 129.5, 130.4, 130.8, 131.1, 134.3,
136.5, 142.2, 145.8, 154.5, 163.5, 169.3.
2,3-Dihydro-2-phenylquinazolin-4(1H)-one (8a) mp: 225–227 °C; IR (KBr,
1
cm-1): 1,508, 1,610, 1,653, 3,062, 3,302; H NMR (400 MHz, CDCl3): d = 5.76
(s, 1H), 6.68 (t, J = 7.4 Hz, 1H), 6.76 (d, J = 8.09 Hz, 1H), 7.10 (br s, NH), 7.25 (t,
J = 7.3 Hz, 1H), 7.33–7.41 (m, 3H), 7.50 (d, J = 7.44 Hz, 2H), 7.62 (d,
J = 7.7 Hz, 1H), 8.28 (br s, NH); 13C NMR (100 MHz, CDCl3): d = 67.4,
115.2, 115.8, 117.9, 127.7, 128.2, 129.1, 129.3, 134.1, 142.5, 148.7, 164.4.
2-(4-Chlorophenyl)-2,3-dihydroquinazolin-4(1H)-one (8b) mp: 201–203 °C; IR
(KBr, cm-1): 1,292, 1,483, 1,650, 1,667, 3,025, 3,307; 1H NMR (400 MHz,
CDCl3): d = 5.77 (s, 1H), 6.70 (t, J = 8.1 Hz, 1H), 6.95 (d, J = 6.4 Hz, 1H), 7.15
(br s, 1H, NH), 7.22–7.47 (m, 3H), 7.51 (d, J = 8.8 Hz, 2H), 7.61 (dd, J1 = 7.8 Hz,
J2 = 1.3 Hz, 1H), 8.34 (br s, NH); 13C NMR (100 MHz, CDCl3): d = 65.8, 114.4,
115.1, 117.27, 127.3, 128.3, 128.7, 132.9, 133.3, 140.7, 147.7, 163.4.
2,4-Dichloro-2,3-dihydroquinazolin-4(1H)-one (8d) mp: 182–184 °C; IR (KBr,
1
cm-1): 1,661, 3,025, 3,179, 3,337; H NMR (400 MHz, CDCl3): d = 6.1 (s, 1 H),
6.71(t, J = 8.1 Hz, 1H), 6.93(d, J = 6.4 Hz, 1H), 7.04 (br s, 1H, NH), 7.24–7.29 (t,
J = 7.5 Hz, 1 H), 7.47–7.50 (m, 1 H), 7.65–7.68 (m, 3 H), 8.25 (br s, NH); 13C
NMR (100 MHz, CDCl3): d = 63.3, 114.6, 114.7, 117.6, 127.4, 128.6, 128.9,
130.9, 132.9, 133.5, 133.9, 136.9, 147.5, 163.6.
2-(4-Bromophenyl)-2,3-dihydroquinazolin-4(1H)-one (8g) mp: 201–203 °C; IR
1
(KBr, cm-1): 1,430, 1,480, 1,651, 1,665, 3,025, 3,188, 3,307; H NMR (400 MHz,
CDCl3): d = 5.76 (s, 1H), 6.67–6.77 (m, 2H), 7.15 (s, 1H, NH), 7.25 (dt,
J1 = 7.7 Hz, J2 = 1.5 Hz, 1H), 7.45 (d, J = 8.6 Hz, 2H), 7.58–7.62 (m, 3H), 8.35
123